Latest & greatest articles for endometriosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on endometriosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on endometriosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for endometriosis

121. Systematic review of the role of self-management among women diagnosed with endometriosis

Systematic review of the role of self-management among women diagnosed with endometriosis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2016 PROSPERO

122. The management of menopause in women with a past history of endometriosis: a systematic review

The management of menopause in women with a past history of endometriosis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2016 PROSPERO

123. Pregnancy rates after intra-uterine insemination in moderate to severe endometriosis: a systematic review and meta-analysis

Pregnancy rates after intra-uterine insemination in moderate to severe endometriosis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2016 PROSPERO

124. Women's experiences of living with endometriosis: a review and synthesis of qualitative research

Women's experiences of living with endometriosis: a review and synthesis of qualitative research Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2016 PROSPERO

125. Clinical efficacy of add-back therapy associated with GnRH-a in treating endometriosis: a meta-analysis

Clinical efficacy of add-back therapy associated with GnRH-a in treating endometriosis: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2016 PROSPERO

126. The miRNA Mirage: how close are we to finding a non-invasive diagnostic biomarker in endometriosis? A systematic review

The miRNA Mirage: how close are we to finding a non-invasive diagnostic biomarker in endometriosis? A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2016 PROSPERO

127. Non-invasive diagnosis of endometriosis: an overview of Cochrane reviews

Non-invasive diagnosis of endometriosis: an overview of Cochrane reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2016 PROSPERO

128. Bladder endometriosis: a systematic review on pathogenesis, diagnosis, treatment, impact on fertility and risk of malignant transformation

Bladder endometriosis: a systematic review on pathogenesis, diagnosis, treatment, impact on fertility and risk of malignant transformation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2016 PROSPERO

129. Clinimetric evaluation of patient reported outcome measurements in endometriosis: a systematic review

Clinimetric evaluation of patient reported outcome measurements in endometriosis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2016 PROSPERO

130. A review of the quality and variation of national guidelines on the diagnosis and management of endometriosis: a systematic review

A review of the quality and variation of national guidelines on the diagnosis and management of endometriosis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2016 PROSPERO

131. Assessing the quality of information about endometriosis available on the Internet: a systematic review

Assessing the quality of information about endometriosis available on the Internet: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2016 PROSPERO

132. Capacity building in endometriosis ultrasound: are we there yet? Full Text available with Trip Pro

Capacity building in endometriosis ultrasound: are we there yet? 28191255 2019 01 12 1836-6864 18 4 2015 Nov Australasian journal of ultrasound in medicine Australas J Ultrasound Med Capacity building in endometriosis ultrasound: are we there yet? 129-131 10.1002/j.2205-0140.2015.tb00218.x Menakaya Uche A UA Staff SpecialistObstetrics and Gynecology Calvary Health CareBruce; Director, JUNIC Specialist Imaging and Women's CenterCharnwood Australian Capital TerritoryAustralia. eng Editorial 2015

2015 Australasian journal of ultrasound in medicine

133. The issues surrounding the pre‐operative TVS diagnosis of rectovaginal septum endometriosis Full Text available with Trip Pro

The issues surrounding the pre‐operative TVS diagnosis of rectovaginal septum endometriosis 28191201 2018 11 13 1836-6864 17 1 2014 Feb Australasian journal of ultrasound in medicine Australas J Ultrasound Med The issues surrounding the pre-operative TVS diagnosis of rectovaginal septum endometriosis. 2-3 10.1002/j.2205-0140.2014.tb00082.x Reid Shannon S University of Sydney. Condous George G Acute Gynaecology, Early Pregnancy and Advanced Endosurgery Unit Sydney Medical School University

2015 Australasian journal of ultrasound in medicine

134. Should ureteric assessment be included in the transvaginal ultrasound assessment for women with suspected endometriosis? Full Text available with Trip Pro

Should ureteric assessment be included in the transvaginal ultrasound assessment for women with suspected endometriosis? 28191234 2018 11 13 1836-6864 18 1 2015 Feb Australasian journal of ultrasound in medicine Australas J Ultrasound Med Should ureteric assessment be included in the transvaginal ultrasound assessment for women with suspected endometriosis? 2 10.1002/j.2205-0140.2015.tb00021.x Reid Shannon S Acute Gynaecology Early Pregnancy and Advanced Endosurgery Unit Sydney Medical School

2015 Australasian journal of ultrasound in medicine

135. Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis Full Text available with Trip Pro

Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis The aim of this study was to investigate the role of peripheral blood markers as additional diagnostic tools to transvaginal ultrasound (TVU) findings in the diagnosis of endometriosis.This study included 40 patients undergoing laparoscopy for suspected endometriosis from January to December 2012. Preoperative levels of serum CA125, CA19-9, CEA and mRNA expression levels for survivin and VEGF were obtained. Real-time PCR (...) was used to determine relative gene expression. A new diagnostic score was obtained by deploying the peripheral blood markers to the TVU findings. Statistical methods used were Chi-square, Fisher's, Student's t-test or the Mann - Whitney test.There was a statistically significant difference in serum CA125, survivin and VEGF levels in patients with endometriosis and those without endometriosis (p<0.001, p=0.025 and p=0.009, respectively). False negative TVU findings were noted in 3/13 patients (23.1

2015 Journal of medical biochemistry

136. Urinary biomarkers for the non-invasive diagnosis of endometriosis. (Abstract)

Urinary biomarkers for the non-invasive diagnosis of endometriosis. About 10% of reproductive-aged women suffer from endometriosis which is a costly chronic disease that causes pelvic pain and subfertility. Laparoscopy is the 'gold standard' diagnostic test for endometriosis, but it is expensive and carries surgical risks. Currently, there are no simple non-invasive or minimally-invasive tests available in clinical practice that accurately diagnoses endometriosis.1. To provide summary estimates (...) of the diagnostic accuracy of urinary biomarkers for the diagnosis of pelvic endometriosis compared to surgical diagnosis as a reference standard.2. To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses.Urinary biomarkers were evaluated as replacement tests for surgical diagnosis and as triage tests to inform decisions to undertake surgery for endometriosis.The searches were not restricted to particular study design, language or publication dates

2015 Cochrane

137. A Systematic Review of the Association Between Psychiatric Disturbances and Endometriosis. (Abstract)

A Systematic Review of the Association Between Psychiatric Disturbances and Endometriosis. An association between endometriosis and psychiatric disturbances has been identified by some researchers. The purpose of this systematic review was to consolidate existing empirical findings to clarify the association between endometriosis and psychiatric conditions.We searched three electronic databases (Medline/PubMed, PsychInfo, and ClinicalTrials.gov) using the following search items: "endometriosis (...) " combined with "mood," "bipolar disorder," "major depressive disorder," "anxiety," "psychiatric," "psychosocial," "antidepressants," "antianxiety," "pharmacotherapy," or "psychotherapy."We included all relevant articles published in English. We identified 18 original research studies examining the association between endometriosis and psychiatric symptoms, with a combined total of 999 endometriosis patients being examined.Of the 18 studies examined, 14 reported that endometriosis was associated

2015 Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC

138. Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial (Abstract)

Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial Seventy patients with stage III or IV endometriosis were randomly assigned to 2 groups after conservative surgery. Group O (n = 35) received 3 cycles of a 28-day gonadotropin-releasing hormone agonist (GnRH-a) treatment (goserelin, 3.6 mg) starting 3-5 days postoperatively. Group M (n = 35) received the same treatment starting on days 1-5 of menstruation. Groups were further (...) time in group M was much longer that than that in group O (P =.001), and the bleeding rate in group M was significantly higher than that in group O (P =.024, RR = 1.185). In patients with stage III or IV endometriosis, the efficacy of GnRH-a initiated 3-5 days postoperatively was equivalent to that of GnRH-a initiated on days 1-5 of menstruation. Female patients who initiated GnRH-a treatment 3-5 days postoperatively experienced less uterine bleeding during the first cycle of treatment.© 2015

2015 EvidenceUpdates Controlled trial quality: uncertain

139. Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe?

Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe? Hormone Therapy for the Menopause after Endometriosis Surgery - Friend or Foe? - Evidently Cochrane Search and hit Go By March 12, 2015 // In today’s guest blog, Dr Martin Hirsch explains about endometriosis and treatment choices for women who have the menopause induced because of it. It’s Menopause Week here at Evidently Cochrane and as a team including individual bloggers, Cochrane UK, Healthtalk and Menopause UK (...) with their NHS Change Day campaign to ‘Change the Change’, we are summarising the evidence surrounding the menopause to ensure women get the correct facts from reliable evidence. This blog aims to help women who have had the menopause induced through surgery for endometriosis make more informed health decisions at a time of significant change for their mind and body. Endometriosis – what is it and how do I know if I have it? Most women have heard of the menopause. They fear it, but for a select few women

2015 Evidently Cochrane

140. Gonadotrophin antagonists for pain associated with endometriosis [Cochrane Protocol]

Gonadotrophin antagonists for pain associated with endometriosis [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2015 PROSPERO